WELL
Welltower Inc.$205.05
Sell
Target $70.08
Report: Mar 08, 2026Real Estate • REIT - Healthcare Facilities • Asset-Based OperatorSnapshot
Decision-first overview with recommendation, valuation anchor, and current setup.
Company Overview
Research Snapshot
Price History
Pelican View
Current$205.05-65.8%
Rec: SellConviction: Low
Entry Target
N/A
N/A
Fair Value
$70.08
(66% below current)
Stop Loss
N/A
N/A
Position Size
None
Time Horizon
N/A
Key Metrics
Live Snapshot
Market Data
52 Week High$216.43
52 Week Low$130.29
Avg. 3 Month Volume3.21M
Efficiency
LTM Gross Margin40.1%
LTM EBITDA Margin33.8%
LTM EBIT Margin14.6%
LTM Operating Margin15.0%
LTM ROA1.6%
LTM ROE2.5%
LTM ROIC2.2%
LTM ROCE2.8%
Capital Structure
Market Cap (MM)$138.0B
Enterprise Value (MM)$154.1B
Shares Outstanding689.84M
Total Debt (MM)$21.38B
Cash & Equivalents (MM)$5.21B
LTM Net Debt (MM)$16.17B
LTM Net Debt/EBITDA4.4x
Growth
TTM Rev. Growth35.6%
Last 3-Yr Rev. CAGR22.7%
Last 3-Yr EBITDA CAGR22.6%
Last 3-Yr EPS CAGR63.9%
Valuation
Street Target Price$221.45
LTM EV/Revenue14.2x
LTM EV/Gross Profit35.4x
LTM EV/EBIT97.4x
LTM EV/EBITDA42.0x
LTM P/E147.3x
LTM EV/FCF21.9x
LTM P/FCF19.6x
LTM P/TB2.0x
LTM P/B3.3x
Dividend Yield1.4%
Payout Ratio200.0%
Executive SummarySituation: Current price is $205.05 versus fair value $70.08 (-65.8% expected return), and valuation confidence is stable. Debate: Bull case depends on Debt refinancing of $5.1B 2026 maturities at current 4.4x leverage could highlight dilution needs if equity tapped again, addressing market fear of per-share erosion from 65.3% historical growth. Bear case centers on Dilution from equity issuance impairs per-share FFO as $28.3B raised drove 65.3% share growth, offsetting 35.6% revenue. Conclusion: Recommendation is Sell with no position, pending a materially better risk/reward setup.
Bull Case
Demographic tailwinds lift occupancy 400bps with 20%+ SHOP NOI for 13 quarters; $11B acquisitions at $265k/unit yield 10% organic revenue; WBS AI platform drives margin expansion to 15.2%.
Bear Case
1.3% ROIC <9.5% WACC on $38.2B reinvestments; 65.3% dilution from $28.3B issuances at avg -37.3% net yield; SG&A +642% YoY compresses margins 4.4pts despite stable 40% gross.
Key Catalysts
Near-Term (0-6 months)Impact: High
Debt refinancing of $5.1B 2026 maturities at current 4.4x leverage could highlight dilution needs if equity tapped again, addressing market...
Mid-Term (6-18 months)Impact: High
Welltower's $67.3B asset base, dominated by 2,726 seniors housing properties at $22M average orderly value, supports a liquidation floor of...
Long-Term (18+ months)Impact: Moderate
Welltower relevant now amid 172% 3Y outperformance vs XLRE +12%, but Q4 beats mask dilution risks as leverage rises post-$5.7B pipeline.
Primary Risks
Concern: High
Dilution from equity issuance impairs per-share FFO as $28.3B raised drove 65.3% share growth, offsetting 35.6% revenue.
Concern: Medium
Asset impairment from regulation/labor erodes $55.58B PP&E as $166.5M charged FY2025.
Concern: Medium
Stewardship weak (overall management quality analysis score 2): Proven investment track but value-destructive dilution; strong board (86% in...
Recent Activity
2024-10-29SEC Filing (8-K)
+5.18%Welltower reports Q3 2024 results with 20.7% increase in normalized FFO per share and 12.6% same-store NOI growth
2024-02-14SEC Filing (8-K)
+6.99%Welltower reports Q4 2023 results with 15.7% increase in normalized FFO per share and 12.5% same-store NOI growth
2022-11-10Market Movement
+5.35%Market/Sector Move +5.35%
2022-11-08SEC Filing (8-K)
+8.22%Welltower reports Q3 2022 results with normalized FFO of $0.84 per share
2021-11-05SEC Filing (8-K)
+5.13%Welltower reports Q3 2021 results with normalized FFO of $0.80 per share
Valuation Table
9.7/10Decision Grade
Scenario Range
$50
Bear
$43
Base
$94
Bull
$205